Columbia University: Pancreatic Neoplasms trials

The registry lists 18 Pancreatic Neoplasms studies with Columbia University as lead sponsor. 2 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 1 1Phase 2 5Phase 3 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pancreatic Cancer GeneticsRecruitingNCT01102569
• PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic DiseaseRecruitingNCT01102556
• RNA Precision Oncology in Advanced Pancreatic CancerTerminatedNCT04476537Not applicableResults posted
• Use of PET Imaging to Distinguish Malignant From Benign IPMNTerminatedNCT01104116Not applicableResults posted
• Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)CompletedNCT00996333Phase 2Results posted
• A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic CancerCompletedNCT00882310Phase 2Results posted
• Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With GemzarCompletedNCT00869258Phase 2Results posted
• Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic AdenocarcinomaActive, not recruitingNCT04543071Phase 2
• Bethanechol Prior to Pancreatic SurgeryCompletedNCT03572283Early Phase 1
• Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic AdenocarcinomaCompletedNCT01219829
• Frequency of Methods of Local Invasion of Pancreatic AdenocarcinomaCompletedNCT01129167
• Stool Testing for Pancreatic CancerCompletedNCT01104129
• Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)CompletedNCT01104077
• Validation of a Mouse Model of Pancreatic CarcinogenesisTerminatedNCT01103128
• Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine InsufficiencyWithdrawnNCT01094600Not applicable
• Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)Status unknownNCT01065870Phase 2/3
• Study of CellCept for Advanced Pancreatic CancerCompletedNCT00997958Phase 1
• Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic CancerTerminatedNCT00003851Not applicable